BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34772429)

  • 1. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.
    Lakso M; Vartiainen S; Moilanen AM; Sirviö J; Thomas JH; Nass R; Blakely RD; Wong G
    J Neurochem; 2003 Jul; 86(1):165-72. PubMed ID: 12807436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.
    Mor DE; Daniels MJ; Ischiropoulos H
    Mov Disord; 2019 Feb; 34(2):167-179. PubMed ID: 30633814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
    Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
    J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
    Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
    Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans.
    Cao P; Yuan Y; Pehek EA; Moise AR; Huang Y; Palczewski K; Feng Z
    PLoS One; 2010 Feb; 5(2):e9312. PubMed ID: 20174477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Butoxytetrahydrofuran, Isolated from
    Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
    ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
    Lee SH; Han YT; Cha DS
    Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans.
    Kaur S; Sammi SR; Jadiya P; Nazir A
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
    Marques CR; Pereira-Sousa J; Teixeira FG; Sousa RA; Teixeira-Castro A; Salgado AJ
    Cytotherapy; 2021 Oct; 23(10):894-901. PubMed ID: 34059421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.
    Mor DE; Tsika E; Mazzulli JR; Gould NS; Kim H; Daniels MJ; Doshi S; Gupta P; Grossman JL; Tan VX; Kalb RG; Caldwell KA; Caldwell GA; Wolfe JH; Ischiropoulos H
    Nat Neurosci; 2017 Nov; 20(11):1560-1568. PubMed ID: 28920936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections of
    Kitisin T; Muangkaew W; Sukphopetch P
    Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models.
    Chen M; Vincent J; Ezeanii A; Wakade S; Yerigenahally S; Mor DE
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35790300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.